Frank P. Kroschinsky
Kerpener Str. 62
Koeln, NW 50937, Germany
Koeln, NW 50937, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial.
Journal: Lancet (London, England)
Published: February 19, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party.
Journal: Journal of hematology & oncology
Published: December 27, 2025
A convolutional neural network for fully automated total metabolic tumor volume delineation in patients with aggressive Non-Hodgkin lymphoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 11, 2025
Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMML.
Journal: HemaSphere
Published: September 05, 2025
Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia.
Journal: NPJ precision oncology
Published: May 06, 2025
Granulocyte Colony Stimulating Factor (G-CSF) and Olfactory Function-A Clinical Pilot Study.
Journal: Laryngoscope investigative otolaryngology
Published: November 19, 2024
Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry.
Journal: Annals of hematology
Published: November 06, 2024
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 13, 2024
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?
Journal: Annals of hematology
Published: June 07, 2024
MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms.
Journal: Leukemia
Published: October 04, 2023
Last Updated: 09/26/2026